SC1

Guardian Agriculture names former Tesla, Beta engineering and manufacturing leader Matt Cherouny as Vice President of Supply Chain and Manufacturing

Retrieved on: 
Monday, September 11, 2023
SC1, Vertical, Multimedia, FAA, Agriculture, Supply, Tesla, Transport, Guardian

WOBURN, Mass., Sept. 11, 2023 /PRNewswire/ -- Guardian Agriculture , the leading developer of electric Vertical Take-Off and Landing (eVTOL) systems for commercial-scale sustainable farming, announced that Matt Cherouny has joined the company as vice president of Supply Chain and Manufacturing.

Key Points: 
  • WOBURN, Mass., Sept. 11, 2023 /PRNewswire/ -- Guardian Agriculture , the leading developer of electric Vertical Take-Off and Landing (eVTOL) systems for commercial-scale sustainable farming, announced that Matt Cherouny has joined the company as vice president of Supply Chain and Manufacturing.
  • "Having recently secured approval from the FAA to begin commercial operations, our focus now is implementing a disciplined manufacturing process, and a resilient supply chain to propel it," said Guardian founder and CEO Adam Bercu.
  • "Matt's track record of helping other autonomous companies grow and scale their supply chain and manufacturing operations is exemplary.
  • "I'm thrilled to join the talented team at Guardian and work alongside the team as we transition our technology from prototypes to large-scale manufacturing."

Guardian Agriculture, the first and only eVTOL with FAA approval to operate commercially, announces $20 million in Series A funding

Retrieved on: 
Tuesday, June 20, 2023
SC1, Farmer, Wilbur-Ellis Co. v. Kuther, Vertical, Uber, Multimedia, FAA, Soil, Adobe, Engineering, Sikorsky, Apple, Agriculture, Quality control, BAE, Tesla, Guardian

WOBURN, Mass., June 20, 2023 /PRNewswire/ -- Guardian Agriculture, the leading developer of electric Vertical Take-Off and Landing (eVTOL) systems for commercial-scale sustainable farming – and the first and only eVTOL company with FAA approval to operate commercially nationwide – today announced a Series A fundraise of $20 million. Led by Fall Line Capital, this round will support expansion of commercial operations across farms nationwide and accelerate the ramp-up of large-scale manufacturing of its SC1 aircraft.

Key Points: 
  • Guardian Agriculture, the first and only eVTOL with FAA approval, announces $20 million in Series A funding
    "Customers, investors, and regulators recognize that there's no better application of electric, fully-autonomous aircraft than in commercial farming," Guardian Agriculture Founder and CEO Adam Bercu said.
  • "We have taken a practical approach to building and deploying our technology that puts us well ahead of other eVTOL developers.
  • The Guardian SC1 platform – which already has more than $100 million in customer orders – is the only autonomous, electric, aerial crop protection system designed specifically for large-scale agriculture.
  • Guardian Agriculture will begin commercial operations in support of its Wilbur-Ellis customer in California this summer.

Nurix Therapeutics Presents Data from Studies of Its Targeted Protein Degraders in B Cell Malignancies and Initiates Expansion of NX-2127 Phase 1b Trial in Diffuse Large B Cell Lymphoma and Mantle Cell Lymphoma Indications

Retrieved on: 
Wednesday, June 14, 2023
Lymphoma, CD79B, Central nervous system, University, PD, Chronic lymphocytic leukemia, Cytarabine, SC1, Follicular lymphoma, Lymphoid leukemia, Half-life, DLBCL, Hematology, ICML, IMCL, Non-Hodgkin lymphoma, Survival, Pharmacokinetics, Head, Absorption, BTK, CNS, Etoposide, International Conference on Emerging Infectious Diseases, Primary central nervous system lymphoma, Patient, UCSF, American Society of Hematology, Mantle cell lymphoma, SAN, Memorial Sloan Kettering Cancer Center, AUC, Mouse, Bone marrow, MCL, Therapy, Poster, Society, Conference, Safety, Vaccine, Pharmaceutical industry, Cmax

SAN FRANCISCO, June 14, 2023 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with hematologic malignancies and solid tumors, today announced the presentation of clinical and preclinical data from its targeted protein degradation programs, NX-5948 and NX-2127, which are being evaluated in ongoing Phase 1 clinical trials in patients with relapsed/refractory B cell malignancies. These data are being presented at the 17th International Conference on Malignant Lymphoma (ICML) which is being held June 13-17, in Lugano, Switzerland.

Key Points: 
  • These data are being presented at the 17th International Conference on Malignant Lymphoma (ICML) which is being held June 13-17, in Lugano, Switzerland.
  • Limitations of current covalent and non-covalent BTK inhibitors include the susceptibility to mutational escape as a basis for resistance.
  • Nurix’s BTK degraders have the potential to address these limitations of BTK inhibitors and provide a new therapeutic option for patients.
  • Nurix is announcing plans to initiate two new Phase 1b dose expansion cohorts in the ongoing Phase 1a/1b clinical trial of NX-2127 in patients with relapsed or refractory B-cell malignancies.

Guardian Agriculture's Aircraft Becomes First eVTOL Authorized to Operate in the U.S.

Retrieved on: 
Monday, April 24, 2023
BattleBots, Pressure, Face, SC1, Agriculture, Crop protection, Wilbur-Ellis Co. v. Kuther, Multimedia, FAA, Engineering, Sikorsky, Apple, BAE, Tesla, Environment, Safety, Software, Transport, Renewable energy, Dairy, Guardian

WOBURN, Mass., April 24, 2023 /PRNewswire/ -- Guardian Agriculture, the leading developer of Electric Vertical Take-Off and Landing (eVTOL) systems for commercial-scale sustainable farming, today announced that it has received approval from the U.S. Federal Aviation Administration (FAA) to operate its aircraft nationwide. FAA approval makes Guardian Agriculture the first commercially authorized eVTOL in the U.S., allowing Guardian Agriculture to safely operate its systems across the country, and positioning it as a leader in the eVTOL space and the first to address the fast-growing agricultural use case.

Key Points: 
  • FAA approval makes Guardian Agriculture the first commercially authorized eVTOL in the U.S., allowing Guardian Agriculture to safely operate its systems across the country, and positioning it as a leader in the eVTOL space and the first to address the fast-growing agricultural use case.
  • "eVTOL powered crop protection is better for crops, better for the environment, and better for growers' bottom line," Guardian Agriculture Founder and CEO Adam Bercu said.
  • "With the recent approval from the FAA, Guardian Agriculture is uniquely positioned to change the face of farming for the better.
  • For the first time, we now have a reliable, cost-effective, and sustainable solution in the form of the Guardian SC1.

International Healthcare Executive, Georgina Rizik, to Lead London’s New Life Sciences Innovation District, SC1

Retrieved on: 
Friday, June 24, 2022
Science, Biotechnology, Research, Pharmaceutical, Finance, Oncology, Health, Professional Services, Patient, Heart, Research, Marketing, Foundation, Industry, Organic, University, Roche, Clinical pharmacy, Life, MP, King's Health Partners, Student, Academic health science centre, Regeneration, Health equity, Innovation, MBA, Investment, Cabinet, Boehringer Ingelheim, Education, Creative, CEO, Novartis, Senior, Workforce, Health, NHS, List of life sciences, NHS foundation trust, SC1, Board, Royal Brompton Hospital, Hospital, King's College London, Royal Street, New Orleans, Imperial College London, Economic development, Management, Healthcare, Creative industries, Medicine, Ipsen, Biotechnology, Biotechnology, Pharmacy, Science

SC1, Londons new Life Sciences Innovation District being developed in south central London, UK, has announced the appointment of a new Executive Director, Georgina Rizik.

Key Points: 
  • SC1, Londons new Life Sciences Innovation District being developed in south central London, UK, has announced the appointment of a new Executive Director, Georgina Rizik.
  • Georgina is a leading international healthcare and biotechnology commercial executive with over 25 years experience across private, public and non-profit organisations.
  • Starting in June, Georgina will lead SC1, which was founded by Kings Health Partners, Guys & St Thomas Foundation, and Lambeth and Southwark councils.
  • It is a privilege and honour to be the leader for SC1, Londons Life Sciences Innovation District.

ACM Research Receives Multiple Purchase Orders for Ultra C wb Wet Bench Tools

Retrieved on: 
Sunday, February 13, 2022
NASDAQ, Silicon, FEOL, ULD, DHF, CEO, Research, DIO3, Electroplating, Ownership, IPA, ACM, SC1, Ultra, Technology, NAND, WLP, 3D NAND, Temperature, RCA, CMP, Multiple chemical sensitivity, SC2, BEOL, GLOBE, MRC, Fine chemical, Printed circuit board, DIW

FREMONT, Calif., Feb. 13, 2022 (GLOBE NEWSWIRE) -- ACM Research, Inc. (ACM) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging (WLP) applications, today announced volume purchase orders for 29 Ultra C wb wet bench tools for 300 mm wafer applications. The orders are from multiple China-based customers, and include repeat orders for 16 tools from an emerging foundry customer to support its ongoing fab expansion. Shipments are scheduled in two phases, beginning in the first half of 2022.

Key Points: 
  • Largest purchase order for wet bench systems in ACMs history;
    FREMONT, Calif., Feb. 13, 2022 (GLOBE NEWSWIRE) -- ACM Research, Inc. (ACM) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging (WLP) applications, today announced volume purchase orders for 29 Ultra C wb wet bench tools for 300 mm wafer applications.
  • The orders are from multiple China-based customers, and include repeat orders for 16 tools from an emerging foundry customer to support its ongoing fab expansion.
  • can be supplied in programmed sequences, ACMs Ultra C wb wet bench tool delivers high cleaning performance and eliminates cross-contamination at a lower cost of ownership.
  • The Ultra C wb wet bench tool efficiently uses chemistries and deionized water (DIW), making it environmentally friendly.

Skyharbour Announces Fully-Subscribed Private Placement of Flow-Through Units for $500,000

Retrieved on: 
Thursday, December 23, 2021
Athabasca, Denison Mines, CAD, CSE, Legislation, Minority, Fission Uranium Corp., Preston, Thorium dioxide, Valor, SC1, Private placement, Private, Maverick, Private placement life insurance, Arrow, Exchange, Policy, Project, TSX Venture Exchange, Company, Orano, Uranium, GLOBE, Bank, Security (finance), Multilateral, Cameco, Athabasca Basin, BC, McArthur River

Vancouver, BC, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQB: SYHBF) (Frankfurt: SC1P) (the “Company” or “Skyharbour”) is pleased to announce it is proceeding on a fully-subscribed, non-brokered private placement financing for total gross proceeds of CAD $500,000 (the “Private Placement”). The majority of this smaller financing is being led by insider participation with an independent director providing the lead order.

Key Points: 
  • Vancouver, BC, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH ) (OTCQB: S Y HBF ) (Frankfurt: SC1 P ) (the Company or Skyharbour) is pleased to announce it is proceeding on a fully-subscribed, non-brokered private placement financing for total gross proceeds of CAD $500,000 (the Private Placement).
  • Skyharbour has allotted and plans to issue 1,000,000 units (the Units) at a price of CAD $0.50 per Unit.
  • The Company intends to use the proceeds from this Private Placement for exploration and upcoming drilling programs.
  • Skyharbours Uranium Project Map in the Athabasca Basin:
    To find out more about Skyharbour Resources Ltd. (TSX-V: SYH) visit the Companys website at www.skyharbourltd.com .